Greenland Capital Management LP trimmed its position in shares of Lam Research Corporation (NASDAQ:LRCX - Free Report) by 79.5% in the 2nd quarter, according to its most recent disclosure with the SEC. The institutional investor owned 1,508 shares of the semiconductor company's stock after selling 5,843 shares during the quarter. Greenland Capital Management LP's holdings in Lam Research were worth $653,000 as of its most recent filing with the SEC.
Several other hedge funds have also recently added to or reduced their stakes in the company. Ameritas Advisory Services LLC raised its position in shares of Lam Research by 577.3% in the second quarter. Ameritas Advisory Services LLC now owns 17,704 shares of the semiconductor company's stock valued at $7,672,000 after buying an additional 15,090 shares during the last quarter. Guardian Wealth Advisors LLC NC boosted its position in Lam Research by 20.0% during the second quarter. Guardian Wealth Advisors LLC NC now owns 5,910 shares of the semiconductor company's stock worth $2,561,000 after acquiring an additional 985 shares during the last quarter. Henrickson Nauta Wealth Advisors Inc. acquired a new position in Lam Research during the second quarter worth about $238,000. Wedmont Private Capital grew its stake in Lam Research by 1.4% during the 2nd quarter. Wedmont Private Capital now owns 17,732 shares of the semiconductor company's stock valued at $7,684,000 after acquiring an additional 247 shares in the last quarter. Finally, Kintra Wealth LLC purchased a new stake in Lam Research during the 2nd quarter valued at about $551,000. 84.61% of the stock is owned by institutional investors and hedge funds.
Wall Street Analysts Forecast Growth
LRCX has been the topic of a number of research reports. Stifel Nicolaus raised their target price on shares of Lam Research from $325.00 to $425.00 and gave the stock a "buy" rating in a research note on Friday, July 10th. B. Riley Financial lowered their target price on Lam Research from $385.00 to $350.00 and set a "buy" rating on the stock in a report on Thursday, July 30th. Wall Street Zen lowered Lam Research from a "buy" rating to a "hold" rating in a research report on Sunday, May 10th. Susquehanna reaffirmed a "positive" rating and issued a $475.00 price target (up from $385.00) on shares of Lam Research in a report on Tuesday, June 30th. Finally, Wells Fargo & Company reiterated an "overweight" rating and set a $350.00 price objective (down from $450.00) on shares of Lam Research in a research report on Thursday, July 30th. One analyst has rated the stock with a Strong Buy rating, twenty-six have given a Buy rating and five have issued a Hold rating to the stock. According to MarketBeat.com, the company presently has an average rating of "Moderate Buy" and an average price target of $358.97.
Check Out Our Latest Stock Report on Lam Research
Insider Buying and Selling
In related news, Director Eric Brandt sold 54,500 shares of the stock in a transaction that occurred on Thursday, June 11th. The stock was sold at an average price of $350.80, for a total value of $19,118,600.00. Following the completion of the transaction, the director directly owned 199,205 shares in the company, valued at approximately $69,881,114. This represents a 21.48% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is accessible through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Director Abhijit Talwalkar sold 18,282 shares of the firm's stock in a transaction on Monday, July 13th. The stock was sold at an average price of $335.00, for a total value of $6,124,470.00. Following the sale, the director directly owned 87,142 shares of the company's stock, valued at approximately $29,192,570. This trade represents a 17.34% decrease in their position. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Over the last three months, insiders sold 77,782 shares of company stock worth $26,755,370. Company insiders own 0.31% of the company's stock.
Trending Headlines about Lam Research
Here are the key news stories impacting Lam Research this week:
- Positive Sentiment: Lam Research’s record June-quarter results and outlook remain key catalysts. Revenue reached $6.72 billion, up 30% year over year, while adjusted earnings exceeded analysts’ expectations. Management guided for approximately $8.10 billion in September-quarter revenue, reinforcing confidence in continued AI- and advanced-chip-related demand. Lam Research gains as investors build on strong guidance and recent shareholder-friendly updates
- Positive Sentiment: The company broke ground on a new Oregon research laboratory and plans to invest more than $3 billion in its global lab network over five years. The investment is intended to support semiconductor research tied to artificial intelligence and next-generation chip production. Lam Research Oregon laboratory announcement
- Positive Sentiment: Lam Research raised its quarterly dividend by approximately 27% to $0.33 per share, improving the stock’s shareholder-return profile after its record quarter. Lam Research dividend increase
- Positive Sentiment: Options activity and bullish institutional positioning may be adding to momentum. More than 1,600 institutions reportedly increased their holdings in the latest quarter, while recent analyst targets—including several between $400 and $500—remain above the current trading range. Lam Research options market article
- Neutral Sentiment: The dividend increase has attracted attention as investors seek income and quality amid geopolitical and inflation concerns, although broader market volatility could continue to affect semiconductor stocks. Stocks with dividend hikes article
- Negative Sentiment: Insiders have reported only sales—not purchases—in the past six months, including transactions by CEO Timothy Archer and other executives. That activity may raise concerns about valuation or profit-taking.
- Negative Sentiment: After substantial long-term gains, some commentary argues that LRCX is fully valued, with elevated valuation metrics leaving less room for disappointment-free execution. UBS also recently lowered its price target to $425, despite remaining above the current share price. UBS lowers Lam Research price target
Lam Research Price Performance
Shares of LRCX stock opened at $307.65 on Monday. The company has a debt-to-equity ratio of 0.30, a current ratio of 2.63 and a quick ratio of 1.91. The company has a market capitalization of $384.97 billion, a PE ratio of 53.41, a price-to-earnings-growth ratio of 1.22 and a beta of 1.85. The firm's 50-day moving average is $321.34 and its two-hundred day moving average is $291.79. Lam Research Corporation has a 12 month low of $100.68 and a 12 month high of $438.50.
Lam Research (NASDAQ:LRCX - Get Free Report) last posted its quarterly earnings results on Wednesday, July 29th. The semiconductor company reported $1.82 earnings per share for the quarter, beating the consensus estimate of $1.69 by $0.13. The business had revenue of $6.72 billion during the quarter, compared to analysts' expectations of $6.66 billion. Lam Research had a net margin of 31.27% and a return on equity of 67.60%. The business's revenue for the quarter was up 30.0% on a year-over-year basis. During the same quarter in the prior year, the company posted $1.33 EPS. Lam Research has set its Q1 2027 guidance at 2.000-2.300 EPS. Analysts predict that Lam Research Corporation will post 9.33 earnings per share for the current year.
Lam Research Increases Dividend
The firm also recently disclosed a quarterly dividend, which will be paid on Wednesday, October 14th. Investors of record on Wednesday, September 23rd will be issued a $0.33 dividend. This is a boost from Lam Research's previous quarterly dividend of $0.26. This represents a $1.32 dividend on an annualized basis and a yield of 0.4%. The ex-dividend date is Wednesday, September 23rd. Lam Research's payout ratio is currently 18.06%.
Lam Research Company Profile
(
Free Report)
Lam Research Corporation NASDAQ: LRCX is a global supplier of wafer fabrication equipment and services to the semiconductor industry. Founded in 1980 by David K. Lam and headquartered in Fremont, California, the company develops and manufactures systems used in multiple stages of semiconductor device production, including thin film deposition, plasma etch, wafer cleaning and related process modules and automation.
Lam's product portfolio covers core process technologies employed by logic and memory manufacturers, with equipment designed to support advanced-node patterning, 3D NAND and other emerging device architectures.
Read More

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Lam Research, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Lam Research wasn't on the list.
While Lam Research currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Tesla, Nvidia, and Google helped shape the last era of market growth, but the next wave could come from a new group of companies. Inside this report, you’ll find 7 stocks that could play a major role in the next tech-driven market boom.
Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Like this article? Share it with a colleague.
Link copied to clipboard.